1. GSK aims to make 1B doses of vaccine booster for multiple COVID-19 partners — Protalix and Chiesi get close to potential Fabry disease treatment approval — AstraZeneca locks up COVID-19 vaccine supply with Oxford BioMedica deal — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Dead product

Discussion in 'Otonomy' started by anonymous, Aug 5, 2016 at 9:48 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    100K increase or decrease, what a joke! The Mary Kay reps sell more products than this shit box of a company.
     

  2. anonymous

    anonymous Guest

    Looks like you dropped the MIC a little early, didn't you bud?

    It wasn't very hard to see that this company was made up of nothing but a sham. Hot air. No substance.

    The exec's and MSL's all swore up and down that this was going to be a slam dunk. Can't miss. They had it all figured out.

    Wrong.

    To those of you that recently joined, you should have paid more attention. You should have called and asked those of us who experienced first hand what this group of clowns were doing on the C-Level and management team. The "non-sales reps" knew this was coming, look who is holding the bag now.

    Good luck finding another device job, and if you are really going to hang around and sell Oshitprio, you'll need more than luck. You need a new brain.

    And finally, a much deserved farewell to Dino. Nobody deserved it more than you, except perhaps your CEO, who ultimately was the captain of this disaster.
     
  3. anonymous

    anonymous Guest

     
  4. anonymous

    anonymous Guest


    OTIC is DOWN! 82.81% today on news that OTIVIDEX is a big fat flop. Perhaps all those OTIPRIO sales can bring the stock price back up? LOL!
     
  5. anonymous

    anonymous Guest

    Thats a wrap!!
     
  6. anonymous

    anonymous Guest

    Now that the titanic has hit the iceberg how are the job hunts going? Hilarious!
     
  7. anonymous

    anonymous Guest

    Don't you know that Oshitprio is totally reimbursable? I bet every hospital and ASC is lining up to meet the new sales stars, approve, and implement Oshitprio as we stand here today in every account in the good ole USA. It's going to take over as the biggest blockbuster generic antibiotic every reformulated. They have super sales pros, real go-getters there now. After all they sold devices to ENT doctors, and that market is filled with the best of the best. Beyond the sales magicians recently hired, they have the best and brightest executives in the business. No doubt about that. These folks can polish and shine this big turd Oshitprio into the stratosphere!!!!
     
  8. anonymous

    anonymous Guest

     
  9. anonymous

    anonymous Guest

    LOL!
    "Otonomy is eliminating employment positions and ceasing programs related to the commercialization and market support of OTIPRIO."
    http://investors.otonomy.com/phoenix.zhtml?c=234082&p=irol-news&nyo=0
     
  10. anonymous

    anonymous Guest

    The brilliant leadership finally caught on that it doesn't matter who you hire when you price a product out of the market. What is remarkable is that for a company focused on products for the ear, they never listened to the people actually talking to the accounts. Leadership pointed fingers, stirred up innuendo, blamed the sales team, and trusted one person in particular that completely killed Otiprio before it even launched.
     
  11. anonymous

    anonymous Guest

    To the top.
     
  12. anonymous

    anonymous Guest

    TRUTH
     
  13. anonymous

    anonymous Guest

    Wanna get away...?
     
  14. anonymous

    anonymous Guest

    It's ok, they will land on their feet. :)
     
  15. anonymous

    anonymous Guest

    It looks like D “mic drop” K ate a great deal of crow for Thanksgiving and topped it off with a huge slice of humble pie! I hope they kept it “classy” when you received the news. I’m sure you will land on your feet. It looks like this just wasn’t a good fit with your skill set. Good luck with your future endeavors.
     
  16. anonymous

    anonymous Guest

    One of the problems about Otonomy was the idiot MSL team and director that you hired. They are useless. They came into our office and were promptly kicked out for making false claims. And we reported them.
     
  17. anonymous

    anonymous Guest

    At least yours came into your accounts. Mine were completely unaccounted for. Can’t even remember who mine was.

    What a bust this company was.

    Also... time to move this board to
    LOST CIVILIZATIONS?
     
  18. anonymous

    anonymous Guest

    Why would anyone need a MSL for OshitPrio, the generic Cipro? What's even more funny is some clowns are actually buying the stock thinking the meniere's drug has any chance of success with these bozos running the show. Laughable.